NCT02240004View on ClinicalTrials.gov

Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions
Inflammation
Interventions
DEVICE

SUPRA HFR

usual dialytic prescription for duration, frequency, acid buffer and anticoagulation regimen

Trial Locations (1)

Unknown

HU Reina Sofia, Córdoba

All Listed Sponsors
lead

Hospital Universitario Reina Sofia de Cordoba

OTHER_GOV

NCT02240004 - Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers | Biotech Hunter | Biotech Hunter